Static Systems Group – the Halma plc subsidiary specialising in alarm and communication solutions for the healthcare and custodial sectors – has announced the appointment of Rosie Cunningham Thomas as the company’s new managing director. Cunningham Thomas boasts more than 20 years of strategic and operational leadership experience gained in global corporates, SMEs and start-ups.
Over the past 12 years, Cunningham Thomas has specialised in leading and scaling early stage, innovation-driven health technology companies through critical growth stages to full commercialisation and clinically evidenced market acceptance.
Cunningham Thomas has prior medical CEO experience at Episurf Medical AB, ToHealth Ltd and FreeHand 2010 Ltd. Prior to her business leadership roles, she held several senior commercial positions at Bard BD and Smiths Industries’ medical division.
Most recently, Cunningham Thomas was the CEO at NuVision Biotherapies, a leading regenerative medicine company which develops life-saving biomaterials.
Commenting on her new role, Cunningham Thomas stated: “I’m delighted to be joining Static Systems Group as it starts its next growth phase as part of Halma plc. The Turner family legacy is impressive and, together as the Static Systems Group, we can honour this legacy while also building for the future, in turn creating sustainable and lasting value.”
Cunningham Thomas is a dual UK-US national having emigrated to the UK to marry her English husband. She’s a pharmacist and earned a pharmacy degree from the University of the Sciences in Philadelphia and studied business management at the University of Pennsylvania.
Cunningham Thomas will be based out of the Static Systems Group facility in Wolverhampton.
*Further information is available online at http://www.staticsystems.co.uk